YVONNE ATKINS: Open Payments
NPI 1528297397 · BEDFORD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,387 in 50 payments from 19 companies in 2025. Trend: 2023 $1,832 · 2024 $1,292 · 2025 $1,387
Food & beverage: $1,387
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 6 | $244 |
| Incyte Corporation | 3 | $173 |
| Janssen Biotech, Inc. | 5 | $122 |
| Novartis Pharmaceuticals Corporation | 3 | $97 |
| PFIZER INC. | 4 | $79 |
| AstraZeneca Pharmaceuticals LP | 3 | $79 |
| E.R. Squibb & Sons, L.L.C. | 4 | $79 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $69 |
| Gilead Sciences, Inc. | 3 | $67 |
| PharmaEssentia USA Corporation | 2 | $67 |
Products named: Monjuvi, DATROWAY, Enhertu, Nubeqa, KISQALI, Trodelvy, BESREMI, IMFINZI.
Industry payments across TX — which companies pay providers there.
